Financials
- Market Capitalization 155.7 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
34.53
売上高対価格比率
1.2
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3483 | AKBA Akebia Therapeutics, Inc. - Common Stock | 0.78 USD | -1.27% | -11.36% | -17.89% | -33.90% | 216.14 M USD | ||
| 3632 | DERM Journey Medical Corporation - Common Stock | 5.81 USD | -1.69% | -11.97% | -18.85% | -17.00% | 163.98 M USD | ||
| 3753 | OGI Organigram Global Inc. - Common Shares | 0.93 USD | 0.00% | -1.06% | -11.43% | -34.74% | 125.05 M USD | ||
| 3783 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 1.23 USD | +4.24% | -8.89% | -37.24% | +21.78% | 123.32 M USD |